Sand Grove Capital Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.3M | Buy |
308,254
+112,577
| +58% | +$11.1M | 15.27% | 1 |
|
|
2025
Q1 | $18.1M | Buy |
+195,677
| New | +$18.1M | 15.02% | 4 |
|
|
2024
Q4 | – | Sell |
-340,056
| Closed | -$32.8M | – | 15 |
|
|
2024
Q3 | $32.8M | Sell |
340,056
-95,010
| -22% | -$9.17M | 12.82% | 1 |
|
|
2024
Q2 | $39.9M | Buy |
435,066
+188,475
| +76% | +$17.3M | 11.68% | 3 |
|
|
2024
Q1 | $22.7M | Buy |
246,591
+131,959
| +115% | +$12.2M | 5.2% | 7 |
|
|
2023
Q4 | $10.9M | Sell |
114,632
-168,218
| -59% | -$16M | 2.9% | 11 |
|
|
2023
Q3 | $26.4M | Buy |
+282,850
| New | +$26.4M | 3.29% | 9 |
|